Journey Medical (DERM): microcap biopharma with cash-generating dermatology portfolio and high-upside Emrosi launch. Read here for more analysis.

In his recent address at the opening of the Plaza Court Hotel on Main Street, President Irfaan Ali took aim at public outcry over infrastructure failures ...

South Africans are not merely spectators to the Madlanga Commission; they are stakeholders in its success or failure ...

Unions Pasyno and Pasyki warned on Thursday that the old buildings of Athalassa hospital are ‘structurally unsound, placing ...

Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look at AMGN stock prospects.

A cable car line is being built to serve the mountaintop temple of Pathibhara Devi, a popular pilgrimage destination for Hindus in eastern Nepal. But the area is also revered by the region’s ...

From a portfolio construction perspective, silver works when allocation size is modest, entry is staggered, and exit rules are defined in advance.

Degrader of cancer protein IDO1 prevents cancer immune suppression by cancer and offers promising strategy to support ...

Regular folks who care about wildlife generally know that climate change is bad for polar bears, but they have only vague ...

Sleep quality is another area where users notice improvement. Rather than acting as a sleep aid, Nerve Calm supports ...

Worldwide end user spending on information security is projected to rise from $193 billion in 2024 to $213 billion in 2025, and the pressure behind that growth shows up in one place first: release ...

The report’s lead author, Kaveh Madani, told UCA News that Asia is among the most vulnerable regions to water bankruptcy “because it combines very high demand with heavy reliance on groundwater, ...